First Time Loading...

MaxCyte Inc
LSE:MXCT

Watchlist Manager
MaxCyte Inc Logo
MaxCyte Inc
LSE:MXCT
Watchlist
Price: 297 GBX Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

MXCT Price Targets Summary
MaxCyte Inc

Wall Street analysts forecast MXCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MXCT is 766.76 GBX with a low forecast of 574.56 GBX and a high forecast of 938.64 GBX.

MXCT Lowest Forecast
Wall Street Target
574.56 GBX
93% Upside
MXCT Average Forecast
Wall Street Target
766.76 GBX
158% Upside
MXCT Highest Forecast
Wall Street Target
938.64 GBX
216% Upside
Lowest
Price Target
574.56 GBX
93% Upside
Average
Price Target
766.76 GBX
158% Upside
Highest
Price Target
938.64 GBX
216% Upside
MaxCyte Inc Competitors:
Price Targets
AZTA
Azenta Inc
28% Upside
WAT
Waters Corp
4% Upside
OLK
Olink Holding AB (publ)
15% Upside
RGEN
Repligen Corp
25% Upside
AZTA
Azenta Inc
28% Upside
WAT
Waters Corp
4% Upside
OLK
Olink Holding AB (publ)
15% Upside
RGEN
Repligen Corp
25% Upside
TMO
Thermo Fisher Scientific Inc
10% Upside
CDXS
Codexis Inc
71% Upside
688621
Beijing Sun-Novo Pharmaceutical Research Co Ltd
33% Upside
688315
Novogene Co Ltd
63% Upside

Revenue
Forecast

Revenue Estimate
MaxCyte Inc

For the last 8 years the compound annual growth rate for MaxCyte Inc's revenue is 20%. The projected CAGR for the next 3 years is 18%.

20%
Past Growth
18%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
MaxCyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
MaxCyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

See Also

Summary
MXCT intrinsic value, competitors valuation, and company profile.
DCF Valuation
MXCT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MXCT stock valuation using valuation multiples.
Wall Street Estimates
MXCT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MXCT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MXCT's stock price target?
Price Target
766.76 GBX

According to Wall Street analysts, the average 1-year price target for MXCT is 766.76 GBX with a low forecast of 574.56 GBX and a high forecast of 938.64 GBX.

What is MaxCyte Inc's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for MaxCyte Inc's revenue is 20%. The projected CAGR for the next 3 years is 18%.

ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.